Pharmaceutical Executive
A new, faster recipe for drug development: Chat up regulators. Outsource where you can. And know when to let go.
Pharmaceutical Executive-09-27-2006
Pharmaceutical Executive
The recent settlement between branded and generic companies offers a 'win-win' approach to patent challenges.
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro
2
Merck Planning $70 Billion Investment for US Expansion
3
Amazon and WeightWatchers Partner for DTC Weight Loss Medication Offerings
4
FDA Approves Tezspire as First Biologic Targeting TSLP for Chronic Rhinosinusitis With Nasal Polyps
5
